Literature DB >> 11057857

Ethnic heterogeneity of the factor XIII Val34Leu polymorphism.

F A Attié-Castro1, M A Zago, J Lavinha, J Elion, L Rodriguez-Delfin, J F Guerreiro, R F Franco.   

Abstract

A polymorphism in the coagulation factor XIII gene (FXIII Val34Leu) has been recently described to confer protection for arterial and venous thrombosis and to predispose to intracerebral hemorrhage. At present it is known that FXIII Val34Leu is prevalent in Caucasians, but information upon its distribution in different ethnic groups is scarce. We investigated the prevalence of FXIIIVal34Leu in 450 unrelated subjects of four ethnic groups: 97 Caucasians (Brazilians of European descent and Portuguese), 149 Blacks (Brazilians, and Africans from Cameroon, Zaire and Angola), 40 Asians (Japanese descendents) and 164 Amerindians from South America. PCR amplification of exon 2 of FXIII gene followed by MseI restriction-digestion was employed to define the genotypes. FXIIIVal34Leu was detected in 44.3% of the Caucasians, in 28.9% of the Blacks, in 2.5% of the Asians and in 51.2% of the Amerindians. These data confirm that FXIII Val34Leu is highly prevalent in Caucasians and indicate that it is rarer in populations of African origin. The very high frequency among Amerindians indicates that FXIII Val34Leu is not absent among Asians, and since it has a very low prevalence in Japanese, a heterogeneity in its distribution in Asia may be inferred. Taken together, our data showed that FXIII Val34Leu exhibits a significant ethnic heterogeneity, a finding that is relevant for studies relating this polymorphism with thrombotic and bleeding disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11057857

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  The impact of factor XIIIa V34L polymorphism on plasma factor XIII activity in the Chinese and Asian Indians from Singapore.

Authors:  Chew-Kiat Heng; Suman Lal; Nilmani Saha; Poh-Sim Low; M Ilyas Kamboh
Journal:  Hum Genet       Date:  2003-10-31       Impact factor: 4.132

2.  Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients.

Authors:  Ana Bronić; Goran Ferencak; Renata Zadro; Ana Stavljenić-Rukavina; Robert Bernat
Journal:  Mol Biol Rep       Date:  2007-09-27       Impact factor: 2.316

3.  Association study of polymorphism of FXIIIVal34Leu gene and polycystic ovary syndrome.

Authors:  Xuefeng Wang; Yue Yang; Yanbing Huang; Qiongyao Wang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.

Authors:  Astrid Dossenbach-Glaninger; Mick van Trotsenburg; Christian Oberkanins; Johanna Atamaniuk
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

5.  The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model.

Authors:  Florian M Kovar; Claudia L Marsik; Bernd Jilma; Christine Mannhalter; Christian Joukhadar; Oswald F Wagner; Georg Endler
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

6.  Factor XIII gene V34L mutation in the Lebanese population: another unique feature in this community?

Authors:  Rami A R Mahfouz; Amira S Sabbagh; Dina M R Shammaa; Zaher K Otrock; Ghazi S Zaatari; Ali T Taher
Journal:  Mol Biol Rep       Date:  2007-05-22       Impact factor: 2.316

7.  F13A1 Gene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary Angioplasty.

Authors:  Lucia Ansani; Jlenia Marchesini; Gabriele Pestelli; Giovanni Andrea Luisi; Giulia Scillitani; Giovanna Longo; Daniela Milani; Maria Luisa Serino; Veronica Tisato; Donato Gemmati
Journal:  Int J Mol Sci       Date:  2018-09-14       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.